| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |